HealthCor Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-69,950
| Closed | -$18.7M | – | 29 |
|
|
2022
Q3 | $18.7M | Sell |
69,950
-343,690
| -83% | -$73M | 2.34% | 17 |
|
|
2022
Q2 | $84.4M | Buy |
413,640
+11,980
| +3% | +$2.45M | 8.48% | 1 |
|
|
2022
Q1 | $84.6M | Sell |
401,660
-51,740
| -11% | -$11.3M | 5.64% | 1 |
|
|
2021
Q4 | $109M | Sell |
453,400
-13,430
| -3% | -$3.45M | 5.92% | 3 |
|
|
2021
Q3 | $132M | Buy |
466,830
+127,530
| +38% | +$41.8M | 5.7% | 3 |
|
|
2021
Q2 | $117M | Buy |
339,300
+258,790
| +321% | +$78.4M | 4.7% | 2 |
|
|
2021
Q1 | $22.5M | Buy |
80,510
+70,950
| +742% | +$19.1M | 0.8% | 40 |
|
|
2020
Q4 | $2.34M | Buy |
+9,560
| New | +$2.47M | 0.09% | 48 |
|
|
2020
Q2 | – | Sell |
-48,002
| Closed | -$15.2M | – | 54 |
|
|
2020
Q1 | $15.2M | Buy |
+48,002
| New | +$14.6M | 0.65% | 36 |
|
|
2019
Q4 | – | Sell |
-356,860
| Closed | -$83.1M | – | 61 |
|
|
2019
Q3 | $83.1M | Buy |
+356,860
| New | +$83.1M | 3.14% | 13 |
|
|
2019
Q1 | – | Sell |
-66,780
| Closed | -$20.1M | – | 52 |
|
|
2018
Q4 | $20.1M | Buy |
66,780
+55,170
| +475% | +$17.6M | 0.63% | 33 |
|
|
2018
Q3 | $4.1M | Buy |
+11,610
| New | +$4M | 0.14% | 39 |
|
|
2016
Q4 | – | Sell |
-375,000
| Closed | -$117M | – | 44 |
|
|
2016
Q3 | $117M | Sell |
375,000
-100,000
| -21% | -$29.6M | 7.15% | 3 |
|
|
2016
Q2 | $115M | Buy |
+475,000
| New | +$125M | 6.26% | 6 |
|
|
2016
Q1 | – | Sell |
-47,090
| Closed | -$14.4M | – | 43 |
|
|
2015
Q4 | $14.4M | Buy |
+47,090
| New | +$13.5M | 0.88% | 27 |
|
|
2015
Q3 | – | Sell |
-32,140
| Closed | -$13M | – | 46 |
|
|
2015
Q2 | $13M | Sell |
32,140
-158,560
| -83% | -$63.6M | 0.65% | 33 |
|
|
2015
Q1 | $80.5M | Buy |
+190,700
| New | +$75.2M | 3.84% | 5 |
|
|
2014
Q4 | – | Sell |
-200,000
| Closed | -$66.2M | – | 53 |
|
|
2014
Q3 | $66.2M | Buy |
200,000
+186,000
| +1,329% | +$61.3M | 3.4% | 10 |
|
|
2014
Q2 | $4.41M | Buy |
+14,000
| New | +$4.21M | 0.22% | 45 |
|
|
2014
Q1 | – | Sell |
-27,800
| Closed | -$7.77M | – | 59 |
|
|
2013
Q4 | $7.77M | Buy |
+27,800
| New | +$7.19M | 0.47% | 38 |
|
|
2013
Q3 | – | Sell |
-300,000
| Closed | -$64.6M | – | 59 |
|
|
2013
Q2 | $64.6M | Buy |
+300,000
| New | +$64.1M | 3.9% | 7 |
|
Other funds holding BIIB
HealthCor Management's BIIB Position: Q4 2022 in Review
HealthCor Management sold out of Biogen (BIIB) in Q4 2022, closing a stake of 69,950 shares — an estimated $18.7M sold.
HealthCor Management first reported a position in BIIB in Q2 2013 and held it in 21 quarters. The position peaked at $132M in Q3 2021. 1,031 funds tracked by Wall St. Rank hold BIIB as of Q4 2022.
- HealthCor Management reported no remaining Biogen position as of Q4 2022 after selling out during the quarter.
- HealthCor Management sold 69,950 Biogen shares in Q4 2022, an estimated $18.7M.
- HealthCor Management first reported a position in Biogen in Q2 2013 and held it in 21 quarters.
- HealthCor Management's Biogen position peaked at $132M in Q3 2021.
- 1,031 funds tracked by Wall St. Rank held Biogen as of Q4 2022.
Based on HealthCor Management's 13F filing for Q4 2022, filed 15 Feb 2023.